HIV-1 infection in the brain induces neuronal apoptosis leading to HIV-associated dementia. To explore the underlying mechanism, we developed a murine model by using human peripheral blood mononuclear cell ( 
H
IV-1 infection in the brain induces a neuropathology, termed HIV encephalopathy, that is characterized by astrocytosis, microglial nodules, cell infiltration with macrophages, decreased synaptic density, and selective neuronal loss (1) . These neurodegenerative changes result in cognitive and motor dysfunction, designated HIV-associated dementia. The neuronal damage is caused by apoptosis, as demonstrated histologically in brains from HIV encephalopathy patients (2) and experimentally by in vitro infection with HIV-1 (3). HIV-1 infects macrophages and microglia but not neurons in the infected brain, suggesting an indirect mechanism for HIV-1-induced neuronal apoptosis (4) . A critical contribution of neurotoxic substances released from the infected and͞or activated macrophages͞ microglia, including excitatory amino acids, IL-1␤, and tumor necrosis factor (TNF)-␣, to neuronal apoptosis has been suggested through in vitro studies (5, 6) . However, the precise mechanism for HIV-induced neuronal apoptosis in vivo has not been elucidated yet because of the lack of an appropriate animal model. Although the neuropathogenesis of simian immunodeficiency virus (SIV) or chimeric simian͞HIV (SHIV) in a monkey model has been reported, the molecular mechanism leading to neuronal apoptosis in vivo has not been clarified (7, 8) . We developed an HIV-1-susceptible mouse model by using human peripheral blood mononuclear cell (PBMC)-transplanted nonobese diabetic (NOD)-severe combined immunodeficiency (SCID) (hu-PBMC-NOD-SCID) mice (9) . When infected with either macrophage (M)-tropic or T cell (T)-tropic HIV-1, a systemic infection with high levels of viremia, which led to a progressive CD4 ϩ T cell loss, was reproducibly established in these mice. Using this mouse model, we recently demonstrated a critical contribution of TRAIL to the depletion of HIV-1-uninfected bystander CD4 ϩ T cells in lymphoid organs that is largely responsible for the pathogenesis of AIDS (10) . In the present study, we developed a mouse model that HIV-1 infection extended to central nervous system (CNS). Intraperitoneal administration of LPS to the M-tropic HIV-1-infected hu-PBMC-NOD-SCID mice induced a neuropathology that resembled part of the HIV encephalopathy of human patients, including infiltration of HIV-infected macrophages, astrocytosis, and neuronal apoptosis in the brain. Using this model, we demonstrated a critical contribution of TRAIL to the HIV-1-induced neuronal apoptosis.
Materials and Methods
Reconstitution and HIV-1 Infection of hu-PBMC-NOD-SCID Mice. NOD (NOD͞Shi) scid͞scid (NOD-SCID) mice were used at 6-8 weeks of age. The experimental protocol was approved by the Ethics Review Committee for Animal Experimentation of the participating institutions. Reconstitution with human PBMCs and infection with HIV-1 were performed as described (9) . Briefly, human PBMCs were isolated from a healthy HIV-1-seronegative donor and injected i.p. Five days later, mice were inoculated i.p. with 1,000 ID 50 of JRFL HIV-1 isolate (11), 100,000 ID 50 of NL4-3 (12), or recombinant HIV-1 expressing green fluorescent protein (GFP). The T-tropic HIV-1 expressing GFP (NL-EGFP) was constructed from NL4-3 by inserting an enhanced GFP (EGFP) gene and an internal ribosome entry site (IRES) sequence between gp41 and the nef sequence by PCR-based subcloning. The ATG codon of EGFP was placed 2 bp downstream of gp41 termination codon and nef expression was rescued from insertion of the IRES sequence. The M-tropic HIV-1 expressing GFP (NL-CSFV3-EGFP) was constructed by replacing the V3 sequence in the NL-EGFP with the V3 sequence from JRCSF (11) . One hundred micrograms of LPS (Sigma) was injected i.p. 7 days after HIV-1 inoculation. Three or 21 days later, the brains were fixed in 4% periodate-lysine-paraformaldehyde (PLP) fixative. The brains were cut into four serial coronal sections at the level of corpus callosum, hippocampus, and cerebellum. Then they were subjected to immunohistological analyses.
3 days later, and the brains were subjected to histological analyses.
Immunohistological Staining. Abs against the following molecules were used for PLP fixed section as primary Abs: human CD3 (rabbit polyclonal IgG, Dako), human CD68 (clone PGM1, mouse monoclonal IgG, Dako), glial fibrillary acidic protein (GFAP) (rabbit polyclonal IgG, Dako), HIV-1 gag p24 (clone Kal-1, mouse monoclonal IgG, Dako), and mouse F4͞80 (clone F4͞80, rat monoclonal IgG, Serotec). Detection of the immunohistological staining was performed as described (10) . Nonimmunized rabbit, mouse, and rat Ig (Dako) were used as negative controls. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) staining of frozen sections was carried out using an indirect method as described (10) . Absence of either digoxigenin-labeled dUTP or TdT served as a negative control. DNase-treated sections served as positive controls.
Frozen sections were incubated with Abs against human CD68 (clone PGM1), human TRAIL (clone RIK-2), IL-1␤ (rabbit polyclonal IgG, Endogen, Woburn, MA), human TNF-␣ (rabbit polyclonal IgG, Endogen), human FasL (rabbit polyclonal IgG, Santa Cruz Biotechnology), HIV-1 gag p24 (goat polyclonal IgG, ViroStat, Portland, ME), or the active form of caspase-3 (rabbit polyclonal IgG, R & D Systems). The sections were then incubated with FITC-conjugated secondary Abs as described (10) . Dual-color staining, including TUNEL, was performed FluoroNissl Green (FNG, FMP) (15), NeuroTrace blue fluorescent Nissl stain (FNB, FMP), or anti-microtubule-associated protein (MAP)-2 mAb (clone HM-2, mouse monoclonal IgG, Sigma). HIV gag p24 (Kal-1, Dako) and human CD68 (PGM1, Dako) were also used. Secondary Abs were used as described (10) . Triple-color analysis for GFP, CD68, and TRAIL, TNF-␣, or FasL was also performed as described (10) . An absence of primary Ab was used as a negative control. Sections were covered with Vector Shield mounting medium (Vector Laboratories) and observed under a Zeiss LSM 310 confocal laserscanning microscope.
Serial coronal sections (at least three slices) were scored for the immunostained cells by a single investigator in a blinded manner. All over the sections were evaluated in each sample. Apoptotic cells were also identified using active form of caspase-3 staining and hematoxylin͞eosin (H&E) staining. Cells undergoing apoptosis were identified by characteristic morphology including nuclear fragmentation and cell shrinkage with condensed nuclei on H&E-stained sections. In dual-color detection of GFP and human CD3 or CD68, the percentage of double-positive cells was calculated. In dual-color staining of CD68 or CD3 and TNF-␣, IL-1␤, TRAIL, or FasL, the percentage of double-positive cells in CD68 (Table 1) . Because we observed similar levels of CD3 ϩ T cell migration in mice 28 days after infection (data not shown) and in brains from uninfected mice (21.6 Ϯ 12.3 cps, Table 1 ), these data appear to represent the baseline distribution of T cells and macrophages in hu-PBMC-NOD-SCID mice. We observed no apparent neuropathology excepting sparse astrocytosis in the brains of infected mice (data not shown).
To facilitate the migration of HIV-infected macrophages into the brain, we administered a sublethal dose of LPS (100 g) i.p. to the JRFL-or NL4-3-infected hu-PBMC-NOD-SCID mice 7 days after infection, because LPS has been reported to enhance the transendothelial migration of macrophages and T cells into the brain through its activation (17) . A marked increase in human CD68 ϩ macrophages ( Table 1 , P Ͻ 0.05). These infiltrated cells were mainly localized in the perivascular region of cortex, basal ganglia, hippocampus, and cerebellum. We also found an increased number of GFAP ϩ astrocytes (astrocytosis) and clustering of F4͞80 ϩ microglia (microglial nodule) 3 days after LPS treatment in both JRFL-and NL4-3-infected hu-PBMC-NOD-SCID mice, as well as HIV-uninfected hu-PBMC-NOD-SCID and untransplanted NOD-SCID mice, compared with mice that were not treated with LPS (Fig. 1, Table 1 ), indicating that these features were independent of HIV-1 infection.
Neuronal apoptosis is a hallmark of HIV encephalopathy leading to neuronal dysfunction (6) . We examined whether our mouse model had such a feature of the disease. After LPS treatment, histological examination clearly demonstrated apoptosis in the brain. We initially performed TUNEL staining for apoptotic cells. The LPS treatment markedly increased the number of TUNEL ϩ apoptotic cells (78.8 Ϯ 21.5 cps in JRFLinfected brains and 33.3 Ϯ 9.36 cps in NL4-3-infected brains) in cortex, basal ganglia, hippocampus, and cerebellum of HIV-1 infected hu-PBMC-NOD-SCID mice (Table 1) Table 1 ). A similar level of increase was also observed 21 days after LPS treatment (28 days after infection; Fig. 2a ). To identify apoptotic neurons, we next performed FNG staining to label Nissl bodies in the cytoplasm as a neuron-specific marker, along with TUNEL staining (Fig. 2b) (Fig. 2 b and c) , and we observed these only after LPS treatment and only in the JRFL-infected mice (13.1 Ϯ 4.47 cps in JRFLinfected brains, Table 1 ), not NL4-3-infected mice (Table 1) . We further verified the identity of the apoptotic neurons by dualcolor staining for TUNEL and another neuron-specific marker, anti-microtubule-associated protein (MAP)-2 ( Fig. 2d) . We also confirmed the apoptosis event in the brain of HIV-1-infected mice by immunostaining using an Ab specific for active form of caspase-3 (Fig. 2e) . In addition, we found a modest increase in apoptotic cells (25.0 Ϯ 10.8 cps) in the brain of HIV-uninfected hu-PBMC-NOD-SCID mice at 3 days after LPS treatment (Fig.  2a, Table 1 ), but these cells did not include cFNG ϩ neurons (Table 1 ) and disappeared at 21 days after LPS treatment (data not shown).
These results indicated that LPS treatment of M-tropic JRFL-infected hu-PBMC-NOD-SCID mice induced some neuropathological changes resembling HIV encephalopathy, especially including infiltration of HIV-infected macrophages and neuronal apoptosis in the brain. In contrast, LPS treatment of T-tropic NL4-3-infected hu-PBMC-NOD-SCID mice induced infiltration of only HIV-infected T cells and apoptosis in nonneuronal cells (Table 1) , human T cells, and mouse cells including astrocytes, microglias, and endothelial cells (data not shown). These results indicated that the HIV-infected T cells in the brain were not competent to induce neuronal apoptosis, suggesting a critical role of HIV-infected macrophages. Although this model has limitations, it is possible to examine the mechanism of neuronal damage through invading HIV-1-infected macrophages.
To confirm the requirement of HIV-1-infected macrophage in brain for inducing the neuronal apoptosis, we used recombinant M-(NL-CSFV3-EGFP) and T-tropic (NL-EGFP) HIV-1 expressing GFP as a marker for replicative infection. These recombinant viruses are identical except for the V3 sequence of env that determines the tropism. We infected hu-PBMC-NOD-SCID mice with these viruses and administered LPS. A significant level of systemic infection was established, as estimated by HIV gag p24 plasma levels (data not shown). Both 40-50% of CD68 (Fig. 3) . We could not find infected (GFP ϩ ) CD68 ϩ macrophages in the brain of NL-EGFP-infected mice. Importantly, apoptotic neurons exhibiting a blue cytoplasm with a pink nucleus, observed by dual-color detection with NeuroTrace blue fluorescent Nissl stain (FNB, blue) and TUNEL (red), were frequently found (10.8 Ϯ 4.97 cps) in the M-tropic virus-infected brain, but not in the T-tropic virus- Fig. 1 . Migration of human PBMCs after LPS treatment and neuropathology in the brain of HIV-1-infected hu-PBMC-NOD-SCID mice. hu-PBMC-NOD-SCID mice were infected with JRFL and LPS was administered or not 7 days after infection. Three days later, the brains were subjected to immunohistochemical staining. Single staining for the indicated markers of brains from infected mice with or without LPS treatment is shown. Arrows indicate vessels. One representative mouse in Table 1 is shown. (Scale bars, 100 m.) infected brain (Fig. 3, Table 1 ). These results further substantiated that the HIV-infected macrophages in the brain were necessary for the induction of neuronal apoptosis.
Critical Contribution of TRAIL to Neuronal Apoptosis. We next explored the molecular mechanism for the HIV-mediated neuronal apoptosis in our model. The expression of TNF-␣, IL-1␤, TRAIL, and FasL was examined, because these molecules were reportedly expressed in HIV-1-infected macrophages (6, 18, 19) . Dual-color staining demonstrated that Ϸ40-60% of the infiltrating human CD68 ϩ macrophages expressed TNF-␣, IL-1␤, and͞or TRAIL, but not FasL (data not shown). In contrast, in the HIV-1-uninfected brain, Ϸ40-50% of the infiltrating human macrophages expressed TNF-␣ and͞or IL-1␤, but not TRAIL, after LPS treatment (data not shown). Thus, the expression of TRAIL on infiltrating human macrophages was found to be preferentially augmented in the infected brains after LPS treatment. Furthermore, triple-color analysis after infection with NL-CSFV3-EGFP indicated that TRAIL was expressed in Ϸ50% of HIV-infected CD68 ϩ macrophages and 20% of HIVinfected T cells, whereas TNF-␣ was expressed in Ϸ80% of HIV-infected CD68 ϩ macrophages and FasL was expressed Ϸ30% of the infected T cells but not in the infected CD68 ϩ macrophages (Fig. 4a) . Dual-color staining for apoptotic cells by TUNEL and for human CD68, HIV gag p24, or human TRAIL showed that some apoptotic cells were predominantly apposed to HIV-infected macrophages expressing TRAIL but not to HIV-1-infected T cells (Fig. 4b) . These results suggested that the occurrence of neuronal apoptosis might be associated with the expression of TRAIL in HIV-infected macrophages.
Finally, we examined the contribution of TRAIL, TNF-␣, and FasL to the neuronal apoptosis in the brain of JRFL-infected hu-PBMC-NOD-SCID mice by administering neutralizing mAbs against these molecules at the time of LPS treatment. The infiltration of human CD3 ϩ T cells, human CD68 ϩ macrophages, hu-PBMC-NOD-SCID mice were infected with M-tropic NL-CSFV3-EGFP or T-tropic NL-EGFP, and LPS was administered or not 7 days after infection. Brains were retrieved 10 days after infection and subjected to histological analysis for GFP (green) and CD68 (red), or FNB (blue) and TUNEL (red). In FNB͞TUNEL staining, cytoplasmic FNB ϩ (cFNB ϩ ) TUNEL ϩ apoptotic neurons have a blue cytoplasm and a pink nucleus, which is merged with blue and red, as indicated by the arrow. (Scale bars, 10 m.) and HIV gag p24 ϩ cells in the brain was not affected by the administration of these mAbs (data not shown). Neuronal apoptosis was significantly inhibited by the anti-human TRAIL mAb (RIK-2; P ϭ 0.0005 by Welch's t test), but not by the anti-human TNF-␣ mAb (28401.111) or the anti-human FasL mAb (NOK-1), as compared with control mouse IgG ( Table 2) . These results indicated a critical contribution of human TRAIL to the neuronal apoptosis in the brain of M-tropic HIV-1-infected hu-PBMC-NOD-SCID mice.
Discussion
In the present study, we developed a murine model of the HIV-CNS infection. In HIV-infected hu-PBMC-NOD-SCID mice without LPS treatment, no neuropathological changes excepting sparse astrocytosis were found. On the other hand, LPS treatment significantly induced the migration of HIVinfected T cells and macrophages into brain, along with the appearance of intense astrocytosis and microglial nodule. However, the same levels of astrocytosis and microglial nodules were also induced in uninfected mice with LPS treatment, indicating that these pathological changes did not solely result from HIV infection in brain. Although our murine model was contrived to a model of HIV encephalopathy, we cannot fully address the mechanism. Most importantly, however, neuronal apoptosis was specifically induced in infected brain region through migration of HIV-infected macrophages but not T cells after LPS treatment. Thus, we used this model to explore the cellular and molecular mechanism for the HIV-induced neuronal apoptosis in vivo.
Administration of LPS to the HIV-1-infected mice induced infiltration of the HIV-infected human macrophages and T cells into the perivascular region of the brain tissue. This effect of LPS seemed to be mediated by an increased expression of integrin very late antigen 4 (VLA-4) on human macrophages and T cells and an increased expression of vascular cell adhesion molecule 1 (VCAM-1) on the endothelium in the brain (unpublished observation). It has been reported that human VLA-4 could interact with mouse VCAM-1 (20) and that transendothelial migration of human T cells and macrophages was augmented with LPS treatment (21) . Consistent with this idea, an increased expression of VCAM-1 has been implicated in the migration of macrophages into the brain during HIV and simian immunodeficiency virus (SIV) infection (22) . LPS is an endotoxin produced by Gram-negative bacteria and has a potent stimulatory effect on endothelial cells and macrophages͞microglia (23) . It has been proposed that some factor associated with advanced HIV infection in the periphery is an important trigger for the infiltration of HIV-infected macrophages into the brain that leads to neuronal apoptosis (6) . In fact, increased expression of human leukocyte antigen (HLA)-DR on human T cells and TRAIL and TNF-␣ on human macrophages was observed after LPS treatment (data not shown). These changes might be induced by activation of macrophages directly by LPS or indirectly by proinflammatory cytokines, such as TNF-␣ and IL-1␤, secreted from these cells. This result suggests that similar changes in patients with HIV encephalopathy may be also mediated by a similar mechanism.
Using this model, we demonstrated that HIV-1 infection in the brain-infiltrating cells is essential for the induction of neuronal apoptosis. Apoptotic neurons were found only in the perivascular region of brains from M-tropic virus-infected mice after LPS treatment. In our mouse model, a large number of CD3 ϩ T cells was also infiltrated into brain tissue coincidentally with infiltration of macrophages. This is apparently different from the pathological feature of HIV-infected human or SIV-infected monkey brain, and may represent a limitation of our mouse model. However, the level of TRAIL expression on HIV-1-infected macrophages in the brain was higher than that on HIV-1-infected T cells, suggesting that the TRAIL molecules expressed on HIV-1-infected macrophages have a critical role in the development of neuronal apoptosis. This requirement of HIV-infected macrophages for neuronal apoptosis is consistent with previous observations in the specimens from HIV encephalopathy patients (2) and in the brains of SCID mice inoculated intracerebrally with HIV-1-infected human macrophages (24) . These findings suggest that macrophage activation by HIV Fig. 4 .
Association of apoptotic cells with HIV-1-infected macrophages expressing death-inducing molecules. (a) Expression of TRAIL, TNF-␣, or FasL on HIV-1-infected macrophage. hu-PBMC-NOD-SCID mice were infected with M-tropic NL-CSFV3-EGFP and LPS was given or not 7 days after infection. Three days later, brain sections were subjected to histological analysis for GFP (green), human CD68 (red), and human TRAIL, TNF-␣, or FasL (blue) simultaneously. A representative cell is shown. (Scale bars, 10 m.) (b) hu-PBMC-NOD-SCID mice were infected with JRFL, and LPS was given 7 days after infection. Three days later, brain sections were subjected to dual-color staining for human CD68, HIV gag p24, or human TRAIL (green) and TUNEL (red). (Scale bars, 100 m.) hu-PBMC-NOD-SCID mice were infected with the JRFL strain of HIV-1 and given LPS and the indicated neutralizing mAb 7 days after infection. Three days later, mice were killed and brains were subjected to histological analyses. Data are indicated as the mean Ϯ SD of the number of TUNEL ϩ cells and TUNEL ϩ cFNG ϩ cells per slice from five to eight mice. *P Ͻ 0.05 compared with control mouse IgG by Welch's t test.
infection itself or by M-tropic viral proteins might induce neurotoxicity. In this respect, it is noteworthy that the infection with a recombinant M-tropic virus (NL-CSFV3-EGFP), but not with a T-tropic virus (NL-EGFP), was neuropathogenic, because these viruses differ only in their V3 sequence of env. This result further substantiates that the ability of HIV-1 to infect macrophages plays a key role in the induction of neuronal apoptosis.
We further explored the molecular mechanism for the HIVinfected cell-mediated neuronal apoptosis by using our model. The brain-infiltrating cells expressed TRAIL in an HIV infection-dependent manner, whereas TNF-␣ and IL-1␤ were expressed independent of HIV infection after LPS treatment. TRAIL was preferentially expressed in HIV-infected cells especially macrophages, which were apposed to apoptotic neurons (Fig. 4b) . More important, administration of a neutralizing anti-TRAIL mAb markedly inhibited the neuronal apoptosis in the brain (Table 2 ). In addition, we recently found significant up-regulation of TRAIL expression on macrophages in brain tissues of HIV encephalopathy patients (Y.M., unpublished data). These results revealed a critical role of TRAIL expressed on HIV-infected cells in neuronal apoptosis. TRAIL expression in HIV-infected cells might be induced by HIV-1 tat, as recently demonstrated (18) , or by IFN, as previously demonstrated in peripheral blood monocytes in vitro (25) . We also confirmed the high level of TRAIL expression on in vitro cultured HIV-1-infected, monocyte-derived macrophages (Y.M., unpublished data). The neurotoxic effect of human TRAIL was further verified against primary cultured neuronal͞glial cells from fetal mice in vitro (Y.M., unpublished data). In this system, however, it remains to be determined whether TRAIL can induce apoptosis in neurons directly or whether it might act indirectly to stimulate glial cells to produce neurotoxic substances such as excitatory amino acids. However, it has been demonstrated that TRAIL directly induced apoptosis for neuronal cells in vitro (26) . TRAIL-induced apoptosis is controlled by the expression of death-inducing or decoy receptors and intracellular proteins such as c-FLIP (cellular FLICE-inhibitory protein; ref. 27 ). Furthermore, it has recently been reported that a death-inducing TRAIL receptor was constitutively expressed on neurons (28) . Further studies are needed to elucidate the molecular mechanisms for the TRAIL expression in HIV-infected macrophages and the TRAIL-mediated neuronal apoptosis.
In conclusion, this study has shown a critical role of TRAIL expressed on HIV-infected cells for neuronal apoptosis in the CNS of our murine HIV-1-infected model. This result suggests that a similar mechanism may be operative in the pathogenesis of HIV-associated dementia in early stages. We also previously demonstrated a critical contribution of TRAIL to the depletion of HIV-uninfected bystander CD4 ϩ T cells in lymphoid organs, a step leading to AIDS (10) . Therefore, TRAIL may be an important target for therapeutic intervention of HIV-associated dementia, as well as AIDS, in HIV-1-infected patients. Further studies in neuropathogenic monkey models are expected to address this possibility.
